Pegloprastide

N/A

Report date: 2025/11/18 20:00:06
NME

Base Information

Drug NamePegloprastide
Drug Alias NameAVB-620
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionDiagnostic imaging enhancers
TargetsNot applicable
Therapy Area/IndicationsBreast NeoplasmsCarcinoma, Ductal, Breast
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVentech Research
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAvelas Biosciences Inc
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsCarcinoma, Ductal, Breast

Other Information

ATC CodeN/A
Related LinksN/A